4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001209191-21-038917
Director sold 19,415 shares at an average $49.07 ($952,613)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Knowles Julius Director | 2021-06-04 | Sale | −2,988 | $47.23 | $141,123 | 552,227 | I: show line 1 in the form |
| Knowles Julius Director | 2021-06-04 | Sale | −1,950 | $47.23 | $92,099 | 370,109 | I: show line 2 in the form |
| Knowles Julius Director | 2021-06-04 | Sale | −1,018 | $48.15 | $49,017 | 551,209 | I: show line 3 in the form |
| Knowles Julius Director | 2021-06-04 | Sale | −663 | $48.15 | $31,923 | 369,446 | I: show line 4 in the form |
| Knowles Julius Director | 2021-06-07 | Sale | −703 | $46.48 | $32,675 | 550,506 | I: show line 5 in the form |
| Knowles Julius Director | 2021-06-07 | Sale | −459 | $46.48 | $21,334 | 368,987 | I: show line 6 in the form |
| Knowles Julius Director | 2021-06-07 | Sale | −786 | $47.34 | $37,209 | 549,720 | I: show line 7 in the form |
| Knowles Julius Director | 2021-06-07 | Sale | −512 | $47.34 | $24,238 | 368,475 | I: show line 8 in the form |
| Open-market sales · 19,415 sh · avg $49.07 · $952,613 | |||||||
Loading xslF345X03/doc4.xml…